Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $6,090 | 3 | 44.9% |
| Consulting Fee | $4,807 | 4 | 35.5% |
| Honoraria | $2,000 | 1 | 14.8% |
| Food and Beverage | $355.21 | 4 | 2.6% |
| Unspecified | $300.00 | 1 | 2.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $10,596 | 6 | $0 (2021) |
| GUERBET LLC | $2,657 | 6 | $0 (2017) |
| Eli Lilly and Company | $300.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $300.00 | 1 | Eli Lilly and Company ($300.00) |
| 2021 | $3,250 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($3,250) |
| 2018 | $557.46 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($557.46) |
| 2017 | $9,445 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($6,788) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/08/2022 | Eli Lilly and Company | — | — | Cash or cash equivalent | $300.00 | Research |
| Study: A MULTICENTER, RANDOMIZED, OPEN LABEL, PHASE 3 TRIAL COMPARING SELPERCATINIB TO PHYSICIANS CHOICE OF CABOZANTINIB OR VANDETANIB IN PATIENTS WITH PROGRESSIVE, ADVANCED, KINASE INHIBITOR NAIVE, RET MUTANT MEDULLARY THYROID CANCER (LIBRETTO 531) | ||||||
| 11/16/2021 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| 01/30/2018 | Bayer HealthCare Pharmaceuticals Inc. | Eovist (Drug) | Consulting Fee | Cash or cash equivalent | $557.46 | General |
| Category: Radiology | ||||||
| 11/13/2017 | Bayer HealthCare Pharmaceuticals Inc. | Eovist (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Radiology | ||||||
| 11/10/2017 | Bayer HealthCare Pharmaceuticals Inc. | Eovist (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Radiology | ||||||
| 10/21/2017 | Bayer HealthCare Pharmaceuticals Inc. | Eovist (Drug) | Food and Beverage | In-kind items and services | $140.60 | General |
| Category: Radiology | ||||||
| 08/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Eovist (Drug) | Travel and Lodging | In-kind items and services | $5,647.86 | General |
| Category: Radiology | ||||||
| 06/12/2017 | GUERBET LLC | DOTAREM (Drug) | Travel and Lodging | Cash or cash equivalent | $108.16 | General |
| Category: MEDICAL IMAGING | ||||||
| 06/12/2017 | GUERBET LLC | DOTAREM (Drug) | Food and Beverage | Cash or cash equivalent | $26.61 | General |
| Category: MEDICAL IMAGING | ||||||
| 01/29/2017 | GUERBET LLC | DOTAREM (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Medical Imaging | ||||||
| 01/29/2017 | GUERBET LLC | DOTAREM (Drug) | Travel and Lodging | In-kind items and services | $334.00 | General |
| Category: Medical Imaging | ||||||
| 01/29/2017 | GUERBET LLC | DOTAREM (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Medical Imaging | ||||||
| 01/29/2017 | GUERBET LLC | DOTAREM (Drug) | Food and Beverage | In-kind items and services | $78.00 | General |
| Category: Medical Imaging | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER, RANDOMIZED, OPEN LABEL, PHASE 3 TRIAL COMPARING SELPERCATINIB TO PHYSICIANS CHOICE OF CABOZANTINIB OR VANDETANIB IN PATIENTS WITH PROGRESSIVE, ADVANCED, KINASE INHIBITOR NAIVE, RET MUTANT MEDULLARY THYROID CANCER (LIBRETTO 531) | Eli Lilly and Company | $300.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,225 | 12,206 | $387,151 | $79,063 |
| 2022 | 23 | 1,149 | 8,738 | $331,608 | $71,162 |
| 2021 | 22 | 1,159 | 5,617 | $298,572 | $68,768 |
| 2020 | 22 | 929 | 2,773 | $219,792 | $53,015 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 168 | 176 | $51,253 | $12,656 | 24.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 57 | 76 | $59,758 | $12,560 | 21.0% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2023 | 25 | 27 | $64,982 | $7,546 | 11.6% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 50 | 75 | $41,817 | $7,200 | 17.2% |
| 74183 | Mri scan of abdomen before and after contrast | Facility | 2023 | 59 | 60 | $21,360 | $5,415 | 25.3% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 104 | 107 | $21,670 | $4,756 | 21.9% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 59 | 62 | $17,429 | $4,253 | 24.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 101 | 106 | $9,540 | $2,997 | 31.4% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Facility | 2023 | 41 | 45 | $10,305 | $2,163 | 21.0% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Facility | 2023 | 24 | 25 | $7,900 | $2,064 | 26.1% |
| 72197 | Mri scan of pelvis before and after contrast | Facility | 2023 | 22 | 22 | $7,832 | $1,989 | 25.4% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 27 | 27 | $7,695 | $1,969 | 25.6% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Facility | 2023 | 21 | 21 | $7,224 | $1,900 | 26.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2023 | 48 | 48 | $5,520 | $1,431 | 25.9% |
| 76705 | Limited ultrasound scan of abdomen | Facility | 2023 | 58 | 58 | $5,336 | $1,352 | 25.3% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 13 | 14 | $11,364 | $1,169 | 10.3% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 25 | 25 | $4,025 | $1,087 | 27.0% |
| 76776 | Ultrasound scan of transplanted kidney | Facility | 2023 | 30 | 32 | $3,776 | $990.32 | 26.2% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 52 | 54 | $3,132 | $966.88 | 30.9% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Facility | 2023 | 21 | 22 | $3,388 | $721.38 | 21.3% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2023 | 28 | 28 | $2,464 | $666.12 | 27.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 62 | 5,475 | $6,629 | $644.64 | 9.7% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 31 | 5,510 | $5,411 | $602.07 | 11.1% |
| 74018 | X-ray of abdomen, 1 view | Facility | 2023 | 46 | 57 | $1,653 | $434.91 | 26.3% |
| 76856 | Complete ultrasound scan of pelvis | Facility | 2023 | 15 | 15 | $1,605 | $409.07 | 25.5% |
About Reena Jha
Reena Jha is a Body Imaging healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548269988.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Reena Jha has received a total of $13,553 in payments from pharmaceutical and medical device companies, with $300.00 received in 2022. These payments were reported across 13 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($6,090).
As a Medicare-enrolled provider, Jha has provided services to 4,462 Medicare beneficiaries, totaling 29,334 services with total Medicare billing of $272,008. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Body Imaging
- Location Washington, DC
- Active Since 07/19/2005
- Last Updated 12/03/2007
- Taxonomy Code 2085B0100X
- Entity Type Individual
- NPI Number 1548269988
Products in Payments
- Eovist (Drug) $7,346
- DOTAREM (Drug) $2,657
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Body Imaging Doctors in Washington
Sandra Allison
Body Imaging — Payments: $1,789
Esma Akin, Md, MD
Body Imaging — Payments: $210.00
Erini Makariou, Md, MD
Body Imaging — Payments: $127.44
Dr. Nadia Khati-Boughanem, M.d, M.D
Body Imaging — Payments: $14.88
Thelma Lopes, M.d, M.D
Body Imaging — Payments: $10.56
Susan Ascher
Body Imaging